CVL006 for advanced solid tumors
Part of Cancer clinical trials.
This study tests a new drug, CVL006, in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective for certain types of cancer, such as non-small cell lung cancer or tumors with high genetic mutations (MSI-H/dMMR or TMB-H).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have an advanced solid tumor that standard treatments have not helped, or for which no standard treatment exists.
- You are willing to provide a tumor tissue sample for testing (either a new biopsy or an archived sample from the last 3 years).
- You are able to perform daily activities with minimal help (ECOG score 0-1).
- You have at least one measurable tumor on scans.
- Your blood counts and organ function (kidney, liver, heart) are within certain limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination treatment (CVL006 plus other drugs) in people with advanced solid tumors that have stopped responding to standard therapies. It aims to see if the combination can shrink tumors and help patients live longer.
This study tests a combination of two experimental cancer-fighting drugs (CVL006 and 9MW2821) in patients with advanced solid tumors, particularly head and neck cancer. The goal is to see if this combination can slow tumor growth and improve outcomes in patients whose cancers have not responded to standard treatments.
This trial tests a new drug called PLB-002 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective, especially for cancers that show a specific marker called CLDN6.
This study tests a new drug called HC006 for advanced solid tumors that no longer respond to standard treatments. It aims to find a safe dose and see if it helps shrink tumors.
This trial tests a new drug called SLV-154 for people whose advanced cancer has not responded to standard treatments. The goal is to see if SLV-154 can shrink tumors or slow cancer growth.
This trial tests an experimental virus therapy called VSV-02 for people with advanced solid tumors that have not responded to standard treatments. The treatment is given directly into a tumor, aiming to attack cancer from the inside.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.